Akadeum develops bioseparation products to facilitate the removal of target cells from biological samples.
Akadeum Life Sciences has raised $2.1M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2026.
Akadeum Life Sciences's investors include Agilent Technologies, Michigan Rise, Genoa Ventures, Arboretum Ventures, Beringea.
Akadeum Life Sciences is headquartered in Ann Arbor, United States.
Akadeum develops bioseparation products to facilitate the removal of target cells from biological samples.
Akadeum Life Sciences is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Akadeum Life Sciences — Funding & Investors." VCBacked, July 9, 2026, https://www.vcbacked.co/company/akadeum-life-sciences. Accessed August 14, 2026.
VCBacked. (2026). Akadeum Life Sciences — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/akadeum-life-sciences
{{cite web |title=Akadeum Life Sciences — Funding & Investors |url=https://www.vcbacked.co/company/akadeum-life-sciences |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated